Fish & Richardson names CEO

25-02-2020

Sarah Morgan

John Adkisson, a patent litigator in Fish & Richardson’s Twin Cities office, has been chosen to lead the firm as principal and CEO.


Fish & Richardson, Peter Devlin, John Adkisson, president, leadership, biosimilar litigation, patent litigation, medical devices, pharma

WIPR